دورية أكاديمية
The diagnostic potential of fluid and imaging biomarkers in chronic traumatic encephalopathy (CTE)
| العنوان: | The diagnostic potential of fluid and imaging biomarkers in chronic traumatic encephalopathy (CTE) |
|---|---|
| المؤلفون: | Bergauer, Anna, van Osch, Robin, van Elferen, Silke, Gyllvik, Sofia, Venkatesh, Hrishikesh, Schreiber, Rudy |
| المصدر: | Bergauer , A , van Osch , R , van Elferen , S , Gyllvik , S , Venkatesh , H & Schreiber , R 2022 , ' The diagnostic potential of fluid and imaging biomarkers in chronic traumatic encephalopathy (CTE) ' , Biomedicine & Pharmacotherapy , vol. 146 , 112602 . https://doi.org/10.1016/j.biopha.2021.112602Test |
| سنة النشر: | 2022 |
| المجموعة: | Maastricht University Research Publications |
| مصطلحات موضوعية: | BLOOD BIOMARKERS, BRAIN-INJURY, Chronic traumatic encephalopathy, EXOSOMAL TAU, Fluid-based biomarkers, Imaging-based biomarkers, Neuroinflammation, POSTCONCUSSION SYNDROME, SYMPTOMS, Tau pathology, Traumatic brain injury |
| الوصف: | Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease characterized by cognitive, affective, and motor dysfunction. The main pathophysiological mechanisms are chronic neuroinflammation, hyper-phosphorylated tau (p-tau) accumulation and neurodegeneration. CTE is mostly caused by exposure to multiple mild traumatic brain injuries, placing people participating in, for example, high contact sports at increased risk. Currently, CTE can solely be diagnosed post mortem based on the spatial pattern of tau-accumulation. Herein, we review candidate imaging and molecular biomarkers for their sensitivity and specificity and we look whether these are sufficient for reliable ante mortem diagnosis. Of the imaging biomarkers, PET appears to have the best potential. Candidate fluid biomarkers consist of genes and proteins found in brain derived extracellular vesicles, as well as cerebrospinal fluid (CSF) p-tau levels. However, neither these biomarkers nor the imaging biomarkers have the discriminatory power to differentiate between CTE and other tauopathies, highlighting the need for further validation. Future research could incorporate machine learning methodologies to differentiate between the tau accumulation patterns detected by PET/fMRI in Alzheimer's and CTE patients. Additionally, proteomic and metabolomic profiling of CSF and plasma associated with chronic mild traumatic brain injuries could highlight potential biomarkers for identifying at risk patients. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.biopha.2021.112602 |
| الإتاحة: | https://doi.org/10.1016/j.biopha.2021.112602Test https://cris.maastrichtuniversity.nl/en/publications/7038af42-66b0-4fda-8695-68a509e42d85Test |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.2B550C26 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.biopha.2021.112602 |
|---|